Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 10, 2018 - Issue
Submit an article Journal homepage
65
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C

Katherine Heath1 Mathematical Ecology Research Group, Department of Zoology, University of Oxford, Oxford OX1 3PS, UK, [email protected];2 New College, Oxford OX1 3BN, UK, [email protected]Correspondence[email protected]
Pages 539-550 | Published online: 20 Sep 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Giovanni Cenderello, Lucia Taramasso, Domenico Marra, Patrizia Orcamo, Ambra Pasa & Antonio Di Biagio. (2019) HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation. Expert Review of Pharmacoeconomics & Outcomes Research 19:2, pages 189-193.
Read now

Articles from other publishers (2)

Ru Han, Clément François & Mondher Toumi. (2020) Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results. Applied Health Economics and Health Policy 19:1, pages 29-44.
Crossref
ROBERT S. EGERMAN. (2019) New Antiviral Agents for Treatment of Hepatitis C. Clinical Obstetrics & Gynecology 62:4, pages 823-834.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.